Letermovir for the compassionate therapeutic use of cytomegalovirus infection

PURPOSE: Data on the efficacy, dosing and safety of letermovir for the compassionate therapeutic use of CMV infections are limited. METHODS: Clinical and virological efficacy of letermovir was assessed in a retrospective single-centre study of patients who received letermovir for the compassionate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Schubert, Lorenz, Fisecker, Lisa, Thalhammer, Florian, Burgmann, Heinz, Steininger, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817558/
https://www.ncbi.nlm.nih.gov/pubmed/32914220
http://dx.doi.org/10.1007/s10096-020-03990-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817558/
https://www.ncbi.nlm.nih.gov/pubmed/32914220
http://dx.doi.org/10.1007/s10096-020-03990-w

Ejemplares similares